Ideas to Action:

Independent research for global prosperity

X

Global Health Policy Blog

Feed

Red HerringThe Red Herring yesterday published analysis of the business of AIDS vaccines, highlighting the limited public sector funding growth is turning attention to the private sector. Under current circumstances, the private sector has limited motivation to participate. Seth Berkley of IAVI comments:

"In terms of small biotech companies, it would be a death knell for them to go to their investors and say 'Hey we're investing massively in an HIV vaccine'"

The solution, according to Berkley and others, is to create incentives for AIDS research, including prizes, tax credits, or advance purchase commitments such as those proposed to be addressed at the July G8 meeting.

Related Topics:

Disclaimer

CGD blog posts reflect the views of the authors drawing on prior research and experience in their areas of expertise. CGD does not take institutional positions.